Valneva SE

NASDAQ:VALN

Biotechnology

Healthcare
$5.37 +0.19%

+$0.01 today

Market cap
$510.36M
Beta
1.40
P/E (TTM)
-2.9
EPS (TTM)
-$0.80
52W Low $5.06High $12.25

Volume 0.00M

Average 0.09M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$52.89M

FY 2025 · Annual

Investing Cash Flow

-$1.71M

FY 2025 · Annual

Financing Cash Flow

-$621,000.00

FY 2025 · Annual

Cash Flow Statement

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(73.43M)(143.28M)(101.43M)(12.25M)(115.19M)
Depreciation & Amortization14.28M21.04M17.58M19.59M21.75M
Deferred Income Tax3.45M(1.54M)2.8M761K1.07M
Stock-Based Compensation14.51M(8.66M)5.11M7.98M9.53M
Change in Working Capital36.13M(145.98M)(145.06M)(11.57M)(148K)
Accounts Receivables(21.35M)12.4M(2.86M)15.71M13.33M
Inventory(92.37M)84.22M(9.17M)(6.8M)1.03M
Accounts Payables35.24M(14.05M)(17.4M)00
Other Working Capital114.61M(228.55M)(115.65M)(20.48M)(14.51M)
Other Non-Cash Items81.96M33.07M18.25M(71.72M)30.09M
Operating Cash Flow76.9M(245.34M)(202.74M)(67.22M)(52.89M)
Capital Expenditures(93.17M)(29.32M)(14.31M)(16.44M)(4.48M)
Acquisitions (Net)08K(10.95M)00
Purchases of Investments00000
Sales of Investments0000841K
Other Investing Activities55K260K4.6M90.78M1.87M
Investing Cash Flow(93.12M)(29.05M)(20.59M)76.92M(1.71M)
Debt Repayment(3.9M)34.49M75.89M(6.49M)61K
Common Stock Issued166.82M189.84M0030M
Common Stock Repurchased00(240K)00
Dividends Paid00000
Other Financing Activities(8.42M)(9.21M)(12.57M)(19.97M)(30.69M)
Financing Cash Flow154.5M215.12M63.08M30.68M(621K)
Effect of Forex Changes3.96M(828K)(204K)1.81M(3.4M)
Net Change in Cash142.29M(57.21M)(160.45M)42.19M(58.62M)
Free Cash Flow(16.27M)(274.67M)(217.06M)(83.66M)(57.38M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$115.2M
+ D&A$21.8M
+ Stock-Based Comp$9.5M
+ Deferred Tax$1.1M
- Working Capital-$148.0K
+ Other Non-Cash$30.1M
= Operating Cash Flow-$52.9M
- Capex-$4.5M
= Free Cash Flow-$57.4M

Analysis

FY2025 free cash flow is -$57.4M. FCF conversion is 49.8% of net income. Operating cash flow was -$52.9M, with capex of -$4.5M. The largest bridge item is Other Non-Cash at $30.1M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 13, 2026
6-K6-K filingNov 6, 2026
6-K6-K filingOct 15, 2026
6-K6-K filingOct 8, 2026
6-K6-K filingAug 14, 2026

Does VALN generate free cash flow?

Valneva SE (VALN) generated -$57.38M of free cash flow in fiscal 2025.

How much operating cash flow does VALN produce?

Operating cash flow was -$52.89M, before capital expenditures of $4.48M.